W Wallace Harrington Selected Research

GW 9578

1/2007

The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Wallace Harrington Research Topics

Disease

1	Body Weight (Weight, Body) 01/2007
1	Obesity 01/2007
1	Weight Gain 01/2007
1	Weight Loss (Weight Reduction) 01/2007
1	Fibrosis (Cirrhosis) 11/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2006

Drug/Important Bio-Agent (IBA)

2	PPAR gammaIBA 01/2007 - 11/2006
1	GW 7845IBA 01/2007
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 01/2007
1	Insulin (Novolin)FDA Link 01/2007
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2007
1	PPAR alphaIBA 01/2007
1	PPAR deltaIBA 01/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2007
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2007
1	GW 9578IBA 01/2007
1	LipidsIBA 01/2007
1	CollagenIBA 11/2006
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2006
1	Actins (F Actin)IBA 11/2006

Therapy/Procedure

1	Ligation 11/2006